Sir Charles Gairdner Hospital
Hospital
Location:
Nedlands,
Australia (AU)
ISNI: 0000000404375942
ROR: https://ror.org/01hhqsm59
Show on Map:
A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6 (2024)
Hughes BG, Guminski A, Bowyer S, Migden MR, Schmults CD, Khushalani NI, Chang ALS, et al.
Journal article
Genome-wide analyses identify a role for SLC17A4 and AADAT in thyroid hormone regulation (2018)
Teumer A, Chaker L, Groeneweg S, Li Y, Di Munno C, Barbieri C, Schultheiss UT, et al.
Journal article
Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study (2017)
Haycock PC, Burgess S, Nounu A, Zheng J, Okoli GN, Bowden J, Wade KH, et al.
Journal article